New York State Common Retirement Fund’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-45,063
| Closed | -$6.81M | – | 3300 |
|
2022
Q3 | $6.81M | Sell |
45,063
-1,733
| -4% | -$262K | 0.01% | 1019 |
|
2022
Q2 | $6.82M | Sell |
46,796
-22,430
| -32% | -$3.27M | 0.01% | 1047 |
|
2022
Q1 | $8.21M | Buy |
69,226
+3,466
| +5% | +$411K | 0.01% | 1060 |
|
2021
Q4 | $9.06M | Buy |
65,760
+711
| +1% | +$98K | 0.01% | 1048 |
|
2021
Q3 | $9.04M | Buy |
65,049
+7,144
| +12% | +$992K | 0.01% | 1044 |
|
2021
Q2 | $5.62M | Buy |
57,905
+3,298
| +6% | +$320K | 0.01% | 1286 |
|
2021
Q1 | $3.73M | Sell |
54,607
-1,280
| -2% | -$87.5K | ﹤0.01% | 1419 |
|
2020
Q4 | $4.79M | Sell |
55,887
-1,300
| -2% | -$111K | 0.01% | 1275 |
|
2020
Q3 | $3.72M | Buy |
57,187
+1,400
| +3% | +$91K | ﹤0.01% | 1286 |
|
2020
Q2 | $4.08M | Buy |
55,787
+8,200
| +17% | +$600K | 0.01% | 1241 |
|
2020
Q1 | $1.62M | Buy |
47,587
+3,385
| +8% | +$115K | ﹤0.01% | 1510 |
|
2019
Q4 | $2.41M | Sell |
44,202
-3,700
| -8% | -$201K | ﹤0.01% | 1551 |
|
2019
Q3 | $2M | Buy |
47,902
+4,600
| +11% | +$192K | ﹤0.01% | 1644 |
|
2019
Q2 | $1.9M | Buy |
43,302
+7,086
| +20% | +$310K | ﹤0.01% | 1677 |
|
2019
Q1 | $1.86M | Buy |
36,216
+2,100
| +6% | +$108K | ﹤0.01% | 1657 |
|
2018
Q4 | $1.26M | Sell |
34,116
-2,297
| -6% | -$85K | ﹤0.01% | 1779 |
|
2018
Q3 | $1.37M | Hold |
36,413
| – | – | ﹤0.01% | 1912 |
|
2018
Q2 | $1.44M | Sell |
36,413
-2,735
| -7% | -$108K | ﹤0.01% | 1891 |
|
2018
Q1 | $1.01M | Buy |
39,148
+28,448
| +266% | +$732K | ﹤0.01% | 2022 |
|
2017
Q4 | $289K | Sell |
10,700
-8,294
| -44% | -$224K | ﹤0.01% | 2602 |
|
2017
Q3 | $710K | Hold |
18,994
| – | – | ﹤0.01% | 2189 |
|
2017
Q2 | $475K | Buy |
+18,994
| New | +$475K | ﹤0.01% | 2432 |
|